Neogen (NEOG) Competitors $4.74 -0.04 (-0.73%) As of 10:12 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEOG vs. HAE, ICUI, XRAY, QDEL, STAA, CERS, OSUR, UTMD, ANIK, and WSTShould you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry. Neogen vs. Its Competitors Haemonetics ICU Medical DENTSPLY SIRONA QuidelOrtho STAAR Surgical Cerus OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Neogen (NASDAQ:NEOG) and Haemonetics (NYSE:HAE) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership. Do institutionals & insiders hold more shares of NEOG or HAE? 96.7% of Neogen shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 1.1% of Neogen shares are held by company insiders. Comparatively, 1.8% of Haemonetics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has preferable valuation & earnings, NEOG or HAE? Haemonetics has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeogen$924.22M1.11-$9.42M-$2.23-2.13Haemonetics$1.36B2.65$167.68M$3.3122.65 Does the media prefer NEOG or HAE? In the previous week, Haemonetics had 2 more articles in the media than Neogen. MarketBeat recorded 14 mentions for Haemonetics and 12 mentions for Neogen. Haemonetics' average media sentiment score of 0.73 beat Neogen's score of -0.03 indicating that Haemonetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 3 Very Negative mention(s) Neutral Haemonetics 5 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, NEOG or HAE? Neogen has a beta of 1.84, indicating that its share price is 84% more volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.36, indicating that its share price is 64% less volatile than the S&P 500. Is NEOG or HAE more profitable? Haemonetics has a net margin of 12.32% compared to Neogen's net margin of -53.56%. Haemonetics' return on equity of 26.37% beat Neogen's return on equity.Company Net Margins Return on Equity Return on Assets Neogen-53.56% 2.69% 1.82% Haemonetics 12.32%26.37%9.22% Do analysts rate NEOG or HAE? Neogen currently has a consensus price target of $7.50, suggesting a potential upside of 58.06%. Haemonetics has a consensus price target of $96.80, suggesting a potential upside of 29.09%. Given Neogen's higher probable upside, research analysts plainly believe Neogen is more favorable than Haemonetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Haemonetics 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.91 SummaryHaemonetics beats Neogen on 15 of the 17 factors compared between the two stocks. Get Neogen News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEOG vs. The Competition Export to ExcelMetricNeogenMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.02B$10.30B$5.47B$8.89BDividend YieldN/A2.10%5.36%4.13%P/E Ratio-2.1117.2226.4119.70Price / Sales1.1128.37406.20108.23Price / Cash4.6123.5625.8827.49Price / Book0.333.637.895.39Net Income-$9.42M$233.36M$3.15B$248.34M7 Day Performance-3.75%0.66%0.54%0.65%1 Month Performance-19.85%2.10%4.77%4.80%1 Year Performance-68.45%-12.33%32.14%17.53% Neogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEOGNeogen3.8178 of 5 stars$4.75-0.7%$7.50+58.1%-69.4%$1.02B$924.22M-2.112,110Analyst ForecastHAEHaemonetics4.8341 of 5 stars$72.15+1.5%$97.89+35.7%-9.6%$3.47B$1.36B21.803,023ICUIICU Medical4.5662 of 5 stars$128.07+0.3%$192.67+50.4%+11.3%$3.15B$2.38B-33.4415,000XRAYDENTSPLY SIRONA4.8134 of 5 stars$15.48+0.8%$20.36+31.5%-36.3%$3.09B$3.79B-3.4114,000Positive NewsQDELQuidelOrtho4.3258 of 5 stars$27.65-1.4%$44.33+60.3%-13.2%$1.87B$2.78B-5.566,600STAASTAAR Surgical3.9892 of 5 stars$16.68+2.1%$24.63+47.6%-64.8%$826.16M$313.90M-11.581,211CERSCerus2.7594 of 5 stars$1.34flat$3.50+161.2%-19.9%$256.15M$180.27M-13.40290OSUROraSure Technologies2.5129 of 5 stars$3.03+1.0%$3.00-1.0%-29.6%$226.64M$161.63M-7.21840Positive NewsUTMDUtah Medical Products2.8058 of 5 stars$54.89+2.3%N/A-14.8%$178.28M$39.27M14.52180Positive NewsANIKAnika Therapeutics4.1042 of 5 stars$10.92+3.1%$20.00+83.2%-58.2%$156.59M$119.91M-2.81300WSTWest Pharmaceutical Services4.7315 of 5 stars$217.05+0.6%$332.50+53.2%-33.6%$15.60B$2.89B34.0710,600 Related Companies and Tools Related Companies HAE Competitors ICUI Competitors XRAY Competitors QDEL Competitors STAA Competitors CERS Competitors OSUR Competitors UTMD Competitors ANIK Competitors WST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEOG) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neogen Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Neogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
